M. Aguilar

A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen’s disease of the lower extremities

L. Martín, M. González, M. de Troya, 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

Spanish-Portuguese Consensus Statement on the Use of Daylight Photodynamic Therapy With Methyl Aminolevulinate in the Treatment of Actinic Keratosis

C. Serra-Guillén, O. Correia, A. Harto, 2015 .

Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain.

A. Boada, I. Oyagüez, C. Gibbons, 2016, Actas dermo-sifiliograficas.

Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain

A. Boada, I. Oyagüez, C. Gibbons, 2016 .

Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis.

C. Serra-Guillén, O. Correia, A. Harto, 2015, Actas dermo-sifiliograficas.